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Extracts of the tropical Cinderella plant Synedrella nodiflora are used traditionally to
manage convulsive conditions in the West African sub-region. This study sought to
determine the neuronal basis of the effectiveness of these plant extracts to suppress
seizure activity. Using the hippocampal slice preparation from rats, the ability of the extract
to depress excitatory synaptic transmission and in vitro seizure activity were investigated.
Bath perfusion of the hydro-ethanolic extract of Synedrella nodiflora (SNE) caused a
concentration-dependent depression of evoked field excitatory postsynaptic potentials
(fEPSPs) recorded extracellularly in the CA1 region of the hippocampus with maximal
depression of about 80% and an estimated IC50 of 0.06 mg/ml. The SNE-induced fEPSP
depression was accompanied by an increase in paired pulse facilitation. The fEPSP
depression only recovered partially after 20 min washing out. The effect of SNE was not
stimulus dependent as it was present even in the absence of synaptic stimulation.
Furthermore, it did not show desensitization as repeat application after 10 min
washout produced the same level of fEPSP depression as the first application. The
SNE effect on fEPSPs was not via adenosine release as it was neither blocked nor reversed
by 8-CPT, an adenosine A1 receptor antagonist. In addition, SNE depressed in vitro
seizures induced by zero Mg2+ and high K+ -containing artificial cerebrospinal fluid (aCSF)
in a concentration-dependent manner. The results show that SNE depresses fEPSPs and
spontaneous bursting activity in hippocampal neurons that may underlie its ability to abort
convulsive activity in persons with epilepsy.
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INTRODUCTION
The use of plants as a source of drugs is long-standing and
widespread in developing countries (Rates, 2001). It is a
dominant source of therapy for many diseases in Ghana (Abel
and Busia, 2005; Van Andel et al., 2012; Amoateng et al., 2018a).
Plants have frequently also been the source of lead compounds,
from which newer and effective drugs can be developed (Soh and
Benoit-Vical, 2007; Amoateng et al., 2012; Van Andel et al., 2012).
A number of plant products have traditionally been used in the
management of epilepsy in Ghana (Mshana et al., 2000; Adjei,
2017; Amoateng et al., 2018b) and some of these have been
investigated on animal models of seizures with promising efficacy
and minimal side effects (; Stafford et al., 2008; Woode, et al.,
2011a; Woode, et al., 2011b; Amoateng et al., 2012; Mante et al.,
2013; Kukuia et al., 2016).
One of such plants is Synedrella nodiflora, a weed which grows
abundantly in Ghana mainly in water-logged and shady areas.
This plant has a long history of use in Ghana for the management
of epilepsy (Mshana et al., 2000). Previous studies have
demonstrated anticonvulsant (Amoateng et al., 2012),
analgesic (Woode et al., 2009; Amoateng et al., 2015) and
antioxidant effects (Amoateng et al., 2011) of the hydro-
ethanolic extract of this plant, validating its traditional
medicinal use. In addition, acute, sub-acute and sub-chronic
toxicological investigations of the extract reveal minimal or no
observable toxicity in rats (Adjei, et al., 2014a; Adjei, et al., 2014b;
Amoateng et al., 2016). The in vivo models used for the
anticonvulsant studies were chemically and electrically induced
seizures in rats and mice. Although in vivo studies provide useful
functional results, they generally have the disadvantage that, it is
difficult to elucidate underlying cellular mechanism(s) of the
anticonvulsant effects. In order to more completely
characterize and understand how this plant’s extracts produce
the functional outcomes described above, it is necessary to
examine their effects at the cellular level, which affords more
detailed pharmacological investigations and analysis. The effects
of potential anticonvulsant agents on neurons and on appropriate
in vitro seizure models have the advantage of allowing
mechanistic screening of the anticonvulsant agents (Scharfman
and Schwartzkroin, 1990; Kupferberg, 2001; Kreir et al., 2018).
These models involve the use of brain slices of region with low
seizure threshold such as the hippocampal CA1 or CA3 areas
where seizures can be induced either electrically or chemically
(Johnston and Brown, 1986; Wong, 2011). Chemical induction of
seizures can be achieved by simple manipulations of altering ionic
composition of the artificial cerebrospinal fluid (aCSF) such as
lowering calcium concentration (Feng and Durand, 2003; Vogel
and Vogel, 2013) or removing Mg2+ (Anderson et al., 1986; Gean
and Shinnick-Gallagher, 1988; Köhling et al., 2001; Vogel and
Vogel, 2013). Other forms of chemically induced seizures include,
blocking of GABAA receptors or their channels in the presence of
elevated K+ (Hablitz and Heinemann, 1987; Traynelis and
Dingledine, 1988; Khazipov et al., 2015), or activating
glutamate receptors e.g., with kainic acid (Lothman and
Collins, 1981). On the other hand, electrically induced seizures
can produced by patterned electrical stimulation such as the
stimulus train-induced bursts (STIBs) (Stasheff et al., 1985; Tian
et al., 1991; Klapstein and Colmers, 1997; Huberfeld et al., 2015).
In this study, we investigated the actions of the hydro-ethanolic
extract of Synedrella nodiflora (SNE) on evoked excitatory field
potentials recorded in the CA1 area of the hippocampus and on
chemically induced seizures in hippocampal slices. We report
here that SNE depressed the amplitude of fEPSPs and chemically
induced spontaneous burst frequency and amplitude in a
concentration-dependent manner. These effects likely involved




Plant samples were collected from the Botanical Gardens,
University of Ghana, Accra in August 2016. The plant was
identified and authenticated at the Ghana Herbarium,
Department of Plant and Environmental Biology, University of
Ghana, Legon, Accra after which a voucher specimen (PA03/
UGSOP/GH16) was prepared and kept at the same department.
The ethanolic extract was prepared as previously described
(Amoateng et al., 2017). Briefly, the plant stems with leaves
were air-dried for seven days, ground into powder, and cold-
macerated with 70% v/v ethanol in water. The resultant hydro-
ethanolic extract was evaporated using a rotary evaporator (Buchi
Rotavapor® R-300, Flawil, Switzerland) under reduced pressure
to eliminate traces of ethanol. The aqueous portion was frozen at
−20°C and lyophilized (Bench-top Freeze Dryer, Labfreez
Instruments Co., Ltd, Beijing, China). The percentage yield of
dried SNE was calculated (10% w/w) and the extract labeled (as
SNE) and stored in a refrigerator at 4–8°C.
High Performance Liquid Chromatography
An HPLC fingerprint was obtained as previously described
(Amoateng et al., 2017). Briefly, a Perkin Elmer Flexar HPLC
(high performance liquid chromatography), fitted with a PDA
detector and a manual injector was used. The components of SNE
were separated on a µBondapak C18 Column (150 × 4.6 mm,
3 µm) with mobile phase 0.1% formic acid (A) and Methanol (B).
The gradient elution commenced with 100% for 10 min and then
moved to 50% in 40 min. It was kept at 50% for another 10 min
and returned to 100% in 2 min, making a total run time of 62 min.
The flow rate was 1 ml/min and the sample injection were 100 µl
(0.108 g in 1:4 methanol-H2O mixture). The wavelength was set
at 315 nm.
Chemicals and Drugs
SNE was prepared as 20 mg/ml stock solution in an appropriate
artificial cerebrospinal fluid (aCSF, composition described
below), centrifuged at 1,792 g (relative centrifugal force) for
10 min, the supernatant collected, aliquoted and stored frozen
at −20°C. 8-cyclopentyltheophylline (8-CPT) (Sigma-Aldrich,
Poole, Dorset, United Kingdom) was prepared as 2 mm stock
solutions and frozen until use. On the day of use, the stock
solutions were thawed, and aliquots diluted with aCSF to the
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desired concentrations. Each stock preparation was used within
2 weeks and any remnants were discarded.
Brain Slice Preparation
Sagittal hippocampal slices (350–400 μm) were prepared from 15
to 20-day-old Sprague-Dawley rats of either sex. The animals
were killed by cervical dislocation in accordance with the
United Kingdom Government Animals (Scientific Procedures)
Act 1986, and with the approval of the University of Warwick’s
Animal Welfare and Ethical Review Board. The animals were
then decapitated, and the whole brain rapidly removed, and
cerebellum and olfactory bulb discarded. Slices were prepared,
from separated hemispheres, glued on their lateral aspects to the
cutting chuck of a Microm HM 650 V microslicer (Carl Zeiss,
Welwyn Garden City, United Kingdom) in ice-cold (∼4°C) high
Mg2+, low Ca2+ artificial cerebrospinal fluid (aCSF), composed of
(mM): 127 NaCl, 1.9 KCl, 8 MgCl2, 0.5 CaCl2, 1.2 KH2PO4, 26
NaHCO3, 10 D-glucose. Slices were stored in standard aCSF
(containing all the above but with 1 mm MgCl2, and 2 mm
CaCl2) at 35°C for at least 1 h (bubbled with 95% O2 and 5%
CO2) before recording.
Extracellular Recording From Slices
An individual slice was transferred to a recording chamber where
it was suspended on nylon mesh grid, completely submerged in
standard aCSF and perfused at 6 ml/min, to allow all round
perfusion and thus reducing the risk of hypoxia. All perfusion
solutions were bubbled with 95%O2 and 5% CO2 and maintained
at around 32°C. All tubing used had low gas permeability (Tygon;
Fisher Scientific, Loughborough, United Kingdom). In order to
record synaptic responses, a concentric tungsten bipolar metal
stimulating electrode was placed in stratum radiatum in the CA1
region to stimulate afferent Schaffer collaterals/commissural
fibers, at 15 s intervals (100 μs pulses). A single aCSF-filled
glass microelectrode was positioned in the CA1 dendritic
region to record evoked field excitatory postsynaptic potentials
(fEPSPs; filtered at1 Hz-3 kHz). WinLTP® software was used to
control stimulus parameters and acquisition, as well as to record
and analyze the slope of fEPSPs (Anderson et al., 2012).
Experiments on Synaptic Transmission
After ensuring a stable baseline fEPSP recording in standard aCSF
(∼20 min), the mediumwas changed to increasing concentrations
of SNE (0.01, 0.1, and 1.0 mg/ml). The application was done in a
continuous, cumulative manner except where indicated
otherwise. Following application of the last concentration of
SNE, the medium was changed back to standard aCSF. For
determination of paired pulse facilitation (PPF), the afferents
were stimulated twice in succession (50 ms interpulse interval)
and paired pulse ratios (PPR) were determined (pulse 2/pulse 1)
before and after application of SNE. In another set of experiments
to study if SNE caused desensitization, SNE (1 mg/ml) was
applied without any stimulation for 10 min, after establishing
the baseline. Then the tissue was stimulated and SNE washed out
FIGURE 1 | High performance liquid chromatography chromatogram of SNE monitored at 315 nm.
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to recovery, followed by reapplication of SNE under stimulation.
To investigate the possible interaction of SNE with adenosine
receptors, tissues were pretreated with the adenosine A1 receptor
antagonist 8-cyclopentyltheophylline (8-CPT, 4 µm) for 10 min
and subsequently with different concentrations of SNE in the
continued presence of 8-CPT (4 µm). In another set of
experiments, all concentrations of SNE up to the maximum of
1 mg/ml were applied and at their peak effect, 8-CPT (4 µm) was
applied in their presence to investigate possible reversal of the
synaptic depression caused by SNE. IC50 and paired pulse ratio
(PPR) data were all expressed as mean ± SEM.
Seizure Protocol
After establishing a stable baseline of fEPSPs in standard aCSF
(∼5 min), stimulation was halted, and the perfusion medium was
replaced with Mg2+-free, high KCl (4.9 mM) aCSF in order to
induce seizure activity. After 3-4 successive seizure bursts, the
medium was switched to apply increasing concentrations of SNE
(0.01, 0.1, and 1.0 mg/ml in Mg2+-free medium) in a cumulative
fashion. Seizure activity was reversed by reperfusion with normal
aCSF. Electrophysiological recordings were made using Spike2®
software. Burst frequency and size were determined in control
and at the peak of SNE application. All data are expressed as
mean ± SEM.
Data Acquisition, Analysis and Statistics
Drugs/extract were administered for 10 min after control periods
were established. All data are expressed as mean ± SEM and n 
number of slices. Statistical significance of all measures was
determined using Student’s t-test/ANOVA where appropriate
(paired or unpaired for t-test, and one-or-two way ANOVA)
and considered significant at p ≤ 0.05 using GraphPad Prism
for Windows version 5.0 (GraphPad Software, San Diego, CA,
United States). fEPSP amplitudes were normalized by taking the
mean of 4-5 responses prior to drug application and dividing the
rest of the values by this mean. The values were used for average
plots and bar graphs. All graphical representations, were done using
SigmaPlot® (Systat Software Inc., San Jose, CA, United States),
Origin® (Originlab Corporation, MA, United States) and
CorelDraw® (Corel Corporation, Ottawa, ON, Canada).
RESULTS
High Performance Liquid Chromatography
From the chromatogram (Figure 1) two major components were
seen at retention times 42.56 and 46.51 min. The percentage
composition was determined to be 45.72 and 36.88% respectively,
using the areas under the curve (AUCs) as previously reported
(Amoateng et al., 2017).
SNE Depressess Synaptic Transmission by
a Presynaptic Mechanism
SNE depressed fEPSPs in a concentration-dependent manner
with an estimated IC50 of 0.06 mg/ml (Figures 2, 3A).
Approximately 50% of the depressant effect of SNE was
recovered after 20 min of washing out SNE. Under control
conditions the paired pulse ratio (slope of fEPSP 2/slope of
fEPSP1) was above 1 (1.5 ± 0.5) indicating paired-pulse
facilitation (PPF). The paired-pulse ratio increased significantly
above this control level of facilitation in the presence of 0.1 and
1.0 mg/ml SNE (Figure 3B, p < 0.05). The depressant effect of
SNE (1 mg/ml) was not dependent on stimulation of the
hippocampal slices as the response was depressed to similar
FIGURE 2 | (A) Effect of SNE (0.01, 0.1 and 1.0 mg/ml) on slope of
fEPSPs in rat hippocampal slices after a stable baseline perfused with normal
aCSF. (B) The bar graph represents the total effect (calculated as AUCs from
the graph above). (C) Concentration-response curve from SNE (0.01,
0.1, and 1.0 mg/ml) on slope of fEPSPs. Data is mean ± SEM (n  5). ***p <
0.001 compared with baseline, one-way ANOVA followed by a Dunnett’s
multiple comparison test.
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levels in the absence of stimulation (Figure 4). Furthermore,
repeat application of SNE did not lead to an enhanced depressant
effect compared to the single application, 80.5 ± 6.5% vs. 82.7 ±
8.5% (Figure 4A,B, p > 0.05). Pre-treatment of hippocampal
slices with 8-CPT (4 μm) did not prevent or block the ability of
any of the tested doses of SNE to depress fEPSPs (Figure 5).
Furthermore, in another set of slices, when SNE had induced peak
fEPSP depression at the highest concentration tested, subsequent
application of 4 μm 8-CPT did not reverse the synaptic
depression induced by SNE (Figure 6).
FIGURE 3 | (A) A typical recording of paired fEPSP showing pair-pulse facilitation (B) Effect of SNE (0.01, 0.1, and 1.0 mg/ml) on paired pulse ratio in rat
hippocampal slices after a stable baseline perfused with normal aCSF. Data is mean ± SEM (n  5). ***p < 0.001 compared with baseline, one-way ANOVA followed by a
Dunnett’s multiple comparison test.
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SNE Suppresses Seizure-Like Activity
When seizures were induced in slices using a modified aCSF that
contained zero Mg2+ and high K+, two types of spontaneous
activities were observed, low frequency burst (LFBs) and high
frequency bursts (HFBs; Figure 7). Similar to the effect on evoked
fEPSPs, increasing concentrations of SNE (0.01, 0.1, and 1.0 mg/
ml) depressed the seizure activity in a concentration-dependent
manner (Figures 8A,B1). SNE (0.1 and 1 mg/ml) decreased the
frequency of firing of both LFBs and HFBs (p < 0.05) while
0.01 mg/ml had no effect (Figure 8B2; p > 0.05). By contrast, SNE
at all doses tested significantly depressed the amplitude of both
spontaneous events (Figure 8C1,C2; p < 0.05).
DISCUSSION
Resource Identification Initiative
This study showed that SNE had the ability to suppress excitatiory
synaptic activity in the hippocampus, a brain region implicated in
the pathophysiology of certain seizures (Parent et al., 1997; Gunn
and Baram, 2017; Cavarsan et al., 2018; Farrell et al., 2019; Farrell
et al., 2019). This effect was concentration-dependent with relatively
high potency and was not completely reversed after 20 min of
washing out of the extract. The SNE-induced synaptic depression
was accompanied by an increase in paired pulse facilitation
suggesting the involvment of presynaptic mechanisms in the
depression such as decreased neurotransmitter release. Two well
established endogenous presynaptic modulators are excitation in
the hippocampus GABA and adenosine (Xia et al., 2012; Real et al.,
2018). In this regards, the SNE-induced synaptic depression was not
mediated by adenosine through its A1 receptors as this effect was
neither blocked nor reversed by the A1 receptor antagonist 8-CPT.
Furthermore, SNE suppressed in vitro seizure activities induced by
enhancing glutamate-mediated transmission by removal of Mg2+
and increasing K+, ions that play important roles in the excitability
of neurons (Horne et al., 1986; Traynelis and Dingledine, 1988;
Ananthalakshmi et al., 2007; Kombian and Phillips, 2013). The
removal of Mg2+ and the depolarization caused by raising
extracellular K+ combined to produce a hyperexcitatory state in
FIGURE 4 | (A) Effect of SNE (1 mg/ml) on the slope fEPSPs without
stimulation (*SNE 1.0 mg/ml) and with stimulation (SNE 1.0 mg/ml). (B) The
box and whiskers graph is the total effect calculated form the AUCs of the
graph above it. Data is mean ± SEM (n  5). ***p < 0.001 compared with
baseline, one-way ANOVA followed by a Dunnett’s multiple comparison test.
FIGURE 5 | (A) Administration of 8-CPT (4 µM) before SNE (0.01, 0.1
and 1.0 mg/ml) on slope of fEPSPs in rat hippocampal slices after a stable
baseline perfused with normal aCSF. (B) The box and whiskers graph is the
total effect calculated form the AUCs of the graph above it. Data is
mean ± SEM (n  3). ***p < 0.001 compared with baseline, one-way ANOVA
followed by a Dunnett’s multiple comparison test.
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hippocampal neurons due to the removal of voltage-dependent
Mg2+ block of the NMDA receptors (Mayer et al., 1984; Kim and
Robinson, 2011; Clarke et al., 2013; Huang and Gibb, 2014). The
oscillatory discharge of neurons resulting from the above
intervention is thought to be driven by changes in intracellular
calcium (Mangan and Kapur, 2004; Gao and Goldman-Rakic,
2006). Indeed, a decrease in the availability of calcium pre-
synaptically has the potential to decrease release probability,
leading to an enhanced paired pulse facilitation as witnessed
here. Thus, SNE may act at one or more targets to produce the
reduction in epileptiform activity of the hippocampal neurons.
These targets include NMDA and non-NMDA receptors, the
intracellular calcium storage sites, or on voltage-gated sodium,
potassium and calcium channels that ultimately drive action
potentials and bursting behavior in neurons (Rogawski et al.,
2016). It is well established that neuronal excitability is a delicate
balance between glutamate driven excitation and GABA-dependent
inhibition (Petroff, 2002; Calfa et al., 2015; Soukupova et al., 2015;
Page and Coutellier, 2019). It is thus, also possible that SNE acted to
enhance GABAergic inhibition to counterbalance the glutamate-
induced hyper-excitation in this model. This may be through one of
several mechanisms including, release of GABA (Rowley et al.,
2012; Rassner et al., 2016), blockade of GABA reuptake (Rowley,
et al., 2012; Rogawski et al., 2016), inhibition of GABAmetabolizing
enzymes (Treiman, 2001; Silverman, 2018) or direct interaction
with GABA receptors and their channels (Sperk et al., 2004; Mareš
FIGURE 6 | (A) Administration of 8-CPT (4 µM) after SNE (0.01, 0.1
and 1.0 mg/ml) on slope of fEPSPs in rat hippocampal slices after a stable
baseline perfused with normal aCSF. (B) The box and whiskers graph is the
total effect calculated form the AUCs of the graph above it. Data is
mean ± SEM (n  3). ***p < 0.001 compared with baseline, one-way ANOVA
followed by a Dunnett’s multiple comparison test.
FIGURE 7 | Chemically-induced seizure model produces two types of
spontaneous response. (A): Typical recordings of bursts in a hippocampal
slice exposed to zero-Mg2+ high K+ medium. (B,C): Expanded scales from A
showing two types of spontaneous seizure activity induced by zero-
Mg2+ high K+medium: low frequency burst (LFB)-B and high frequency bursts
(HFB)-C.
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and Kubová, 2015; Avoli, 2019). All these possibilities need to be
tested in subsequent studies to complete our understanding of how
this extract produces its in vitro anti-seizure effect. Further to this,
other potential targets of SNE to produce its anti-seizure effect may
include adenosinergic systems (Mareš and Kubova, 2008; Alves
et al., 2018). However, this is unlikely as the depressant effect of SNE
on fEPSP were not affected by 8-CPT, an adenosine receptor A1
receptor antagonist, ruling out presynaptic adenosine A1 receptors.
SNE in this study appeared to be a very efficacious and potent
suppressor of excitatory synaptic transmission given that as little as
1 mg/ml reduced the evoked fEPSP by nearly 80%, requiring only a
fraction of that to reduce it by 50% (estimated IC50  0.06 mg/ml).
FIGURE 8 | SNE suppresses the frequency and amplitude of spontaneous seizure activity induced by zero-Mg2+high K+medium. (A): Trace showing effect of SNE
on chemically induced seizure activity. (B1): Summary bar graph of effect of SNE (1 mg/ml) on the frequency of spontaneous activity. (B2): Summary bar graph showing
concentration dependent effect of SNE on seizure activity. (C1): Summary bar graph of effect of SNE (1 mg/ml) on the amplitude of spontaneous events. (C2): Summary
bar graph showing a concentration-dependent depression of event amplitude by SNE.
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This fEPSP effect of SNE was still significantly present after 20min
washing out of SNE suggesting that the effect can be relatively long
lasting which may reflect a slowly reversible process of the
components of the extract. Similar to its effect on the evoked
fEPSPs, SNE also suppressed spontaneous bursting (both LFBs and
HFBs) activity in hippocampal slices caused by the removal of
Mg2+ that led to a glutamate driven hyperexcitability state. This
effect was also concentration-dependent, resulting in a significant
uppression in the occurrence of bursting and decreasing the
amplitude of remaining bursts. A signifcant proportion of this
depression was still present after 20min washing out of SNE. This
suggests that SNE may produce pharmacokinetically relevant
suppression of seizure activity in vivo, confirming the earlier
reported anti-seizure effects in vivo (Amoateng et al., 2012).
CONCLUSION
This preliminary study has provided cellular evidence in support
of the use of this herbal product in traditional practice to manage
convulsions. It still remains to be determined the exact
mechanism by which SNE does this and the active
components that may be responsible for the neuroactivity of
SNE. Followup studies are being conducted to isolate and purify
the active ingredient(s) in SNE and to investigate the detailed
cellular and molecular mechanism underlying SNE actions.
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